HTLV-1 infection in solid organ transplant donors and recipients in Spain.
Por:
de Mendoza C, Roc L, Benito R, Reina G, Ramos JM, Gómez C, Aguilera A, Rodríguez-Iglesias M, García-Costa J, Fernández-Alonso M, Soriano V and Spanish HTLV Network
Publicada:
9 ago 2019
Resumen:
HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain.
Filiaciones:
de Mendoza C:
Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
Universidad CEU-San Pablo, Madrid, Spain
Roc L:
Hospital Miguel Servet, Zaragoza, Spain
Benito R:
Hospital Lozano Blesa, Zaragoza, Spain
Reina G:
Clínica Universitaria de Navarra, Pamplona, Spain
:
Hospital General Universitario, Alicante, Spain
Gómez C:
Complejo Hospitalario, Toledo, Spain
Aguilera A:
Hospital Conxo-CHUS, Santiago, Spain
Rodríguez-Iglesias M:
Hospital Puerta del Mar, Cádiz, Spain
García-Costa J:
Complejo Hospitalario Universitario, Ourense, Spain
Fernández-Alonso M:
Clínica Universitaria de Navarra, Pamplona, Spain
:
UNIR Health Sciences School and Medical Centre, Calle Almansa 101, 28040, Madrid, Spain.
gold, Green Published
|